{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:56:16Z","timestamp":1790052976246,"version":"4.0.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jagp.2023.08.017","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T05:03:01Z","timestamp":1693717381000},"page":"98-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry"],"prefix":"10.1016","volume":"32","author":[{"given":"Simon","family":"Ducharme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Rohrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Huey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Tatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2023.08.017_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JAD-2009-1120","article-title":"A systematic review of neuropsychiatric symptoms in mild cognitive impairment","volume":"18","author":"Monastero","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2023.08.017_bib0002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2019.00176","article-title":"Neuropsychiatric symptoms as predictors of clinical course in neurodegeneration. A longitudinal study","volume":"11","author":"Santacruz Escudero","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0003","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2021.4363","article-title":"Associations between neuropsychiatric symptoms and neuropathological diagnoses of alzheimer disease and related dementias","volume":"79","author":"Devanand","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.728108","article-title":"Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and Alzheimer's disease: a 12-month follow-up study","volume":"12","author":"Da Silva","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1176\/appi.neuropsych.16090168","article-title":"Psychiatric presentations of C9orf72 mutation: what are the diagnostic implications for clinicians?","volume":"29","author":"Ducharme","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0006","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/brain\/awaa018","article-title":"Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders","volume":"143","author":"Ducharme","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0007","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-170608","article-title":"The pitfall of behavioral variant frontotemporal dementia mimics despite multidisciplinary application of the FTDC criteria","volume":"60","author":"Krudop","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2023.08.017_bib0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1212\/CPJ.0000000000000738","article-title":"Diagnostic experience reported by caregivers of patients with frontotemporal degeneration","volume":"10","author":"Besser","year":"2020","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.jagp.2023.08.017_bib0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4088\/JCP.10m06382oli","article-title":"The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease","volume":"72","author":"Woolley","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","article-title":"Fluid biomarkers in frontotemporal dementia: past, present and future","volume":"92","author":"Swift","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0011","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0012","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","article-title":"Frontotemporal dementia","volume":"35","author":"Olney","year":"2017","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jagp.2023.08.017_bib0013","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","article-title":"Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management","volume":"24","author":"Rabinovici","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jagp.2023.08.017_bib0014","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/diagnostics11040624","article-title":"Cognitive and behavioral manifestations in ALS: beyond motor system involvement","volume":"11","author":"Rusina","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jagp.2023.08.017_bib0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00415-019-09463-1","article-title":"Language impairment in progressive supranuclear palsy and corticobasal syndrome","volume":"268","author":"Peterson","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0016","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/brain\/awac091","article-title":"Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration","volume":"145","author":"Riku","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910298","article-title":"Molecular pathways involved in frontotemporal lobar degeneration with TDP-43 proteinopathy: what can we learn from proteomics?","volume":"22","author":"Mol","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jagp.2023.08.017_bib0019","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","article-title":"Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine","volume":"129","author":"Irwin","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"suppl 1","key":"10.1016\/j.jagp.2023.08.017_bib0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jnc.13588","article-title":"Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies","volume":"138","author":"Mackenzie","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.jagp.2023.08.017_bib0021","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archneurol.2010.254","article-title":"Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness","volume":"67","author":"Geser","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0022","doi-asserted-by":"crossref","first-page":"e890","DOI":"10.1038\/tp.2016.173","article-title":"Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders","volume":"6","author":"Darby","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0023","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00018-016-2416-6","article-title":"Intrinsic disorder in proteins involved in amyotrophic lateral sclerosis","volume":"74","author":"Santamaria","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0024","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.febslet.2015.06.009","article-title":"TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA","volume":"589","author":"Che","year":"2015","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jagp.2023.08.017_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.840357","article-title":"Dysregulation of translation in TDP-43 proteinopathies: deficits in the RNA supply chain and local protein production","volume":"16","author":"Bjork","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0027","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0028","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tibs.2012.03.003","article-title":"TDP-43: gumming up neurons through protein-protein and protein-RNA interactions","volume":"37","author":"Buratti","year":"2012","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0029","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/emboj.2010.310","article-title":"TDP-43 regulates its mRNA levels through a negative feedback loop","volume":"30","author":"Ayala","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.jagp.2023.08.017_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fncel.2015.00423","article-title":"Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS?","volume":"9","author":"Aulas","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0031","doi-asserted-by":"crossref","first-page":"29101","DOI":"10.1073\/pnas.2007806117","article-title":"Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction","volume":"117","author":"Peng","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jagp.2023.08.017_bib0032","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1074\/jbc.RA119.011501","article-title":"Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43","volume":"295","author":"Bhopatkar","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jagp.2023.08.017_bib0033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-010-0764-0","article-title":"Distinct pathological subtypes of FTLD-FUS","volume":"121","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0034","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","article-title":"Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration","volume":"134","author":"Lee","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.24885","article-title":"Typical and atypical pathology in primary progressive aphasia variants","volume":"81","author":"Spinelli","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0036","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1212\/WNL.0000000000012174","article-title":"Primary Progressive Aphasia associated with GRN mutations: new insights into the nonamyloid logopenic variant","volume":"97","author":"Saracino","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0037","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","article-title":"TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis","volume":"7","author":"Van Deerlin","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0038","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jagp.2023.08.017_bib0039","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/07853890.2012.665471","article-title":"The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum","volume":"44","author":"van Langenhove","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.jagp.2023.08.017_bib0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 pathology in Alzheimer's disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jagp.2023.08.017_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.882316","article-title":"Astrocytes in neurodegeneration: inspiration from genetics","volume":"16","author":"Huang","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.724891","article-title":"Contribution of RNA\/DNA binding protein dysfunction in oligodendrocytes in the pathogenesis of the amyotrophic lateral sclerosis\/frontotemporal lobar degeneration spectrum diseases","volume":"15","author":"Valori","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0043","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.14327","article-title":"Pathomechanisms of TDP-43 in neurodegeneration","volume":"146","author":"Gao","year":"2018","journal-title":"J Neurochem"},{"key":"10.1016\/j.jagp.2023.08.017_bib0044","doi-asserted-by":"crossref","first-page":"19437","DOI":"10.1074\/jbc.M116.737726","article-title":"Quantification of the relative contributions of loss-of-function and gain-of-function mechanisms in TAR DNA-binding protein 43 (TDP-43) proteinopathies","volume":"291","author":"Cascella","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jagp.2023.08.017_bib0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jagp.2023.08.017_bib0046","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jagp.2023.08.017_bib0047","doi-asserted-by":"crossref","first-page":"15635","DOI":"10.1074\/jbc.M111.333450","article-title":"TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells","volume":"287","author":"Colombrita","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jagp.2023.08.017_bib0048","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-neuro-071013-014100","article-title":"Translational control in synaptic plasticity and cognitive dysfunction","volume":"37","author":"Buffington","year":"2014","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0049","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","article-title":"TDP-43 proteinopathies: a new wave of neurodegenerative diseases","volume":"92","author":"de Boer","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0050","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0051","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-020-00753-9","article-title":"Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network","volume":"13","author":"Leroy","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jagp.2023.08.017_bib0052","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(21)00341-0","article-title":"Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations","volume":"21","author":"Boeve","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0053","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.91","article-title":"Primary progressive aphasia","volume":"49","author":"Mesulam","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0054","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia","volume":"140","author":"Perry","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0055","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cortex.2018.03.019","article-title":"Apathy in Alzheimer's disease and frontotemporal dementia: Distinct clinical profiles and neural correlates","volume":"103","author":"Kumfor","year":"2018","journal-title":"Cortex"},{"key":"10.1016\/j.jagp.2023.08.017_bib0056","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/brain\/awr195","article-title":"Motor neuron dysfunction in frontotemporal dementia","volume":"134","author":"Burrell","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0057","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0058","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.jagp.2023.08.017_bib0059","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-007-0223-8","article-title":"The neuropathology and clinical phenotype of FTD with progranulin mutations","volume":"114","author":"Mackenzie","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0060","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jagp.2023.08.017_bib0061","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1212\/WNL.0b013e3182735d36","article-title":"Extensive genetics of ALS: a population-based study in Italy","volume":"79","author":"Chio","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0062","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0063","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0064","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.jagp.2023.08.017_bib0065","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1007\/s00415-021-10451-7","article-title":"Heterogeneity of behavioural and language deficits in FTD-MND","volume":"268","author":"Long","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0066","first-page":"e402","article-title":"Amyotrophic lateral sclerosis-frontotemporal dementia: shared and divergent neural correlates across the clinical spectrum","volume":"98","author":"Cividini","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0067","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/jamaneurol.2013.3961","article-title":"TDP-43 pathology, cognitive decline, and dementia in old age","volume":"70","author":"Wilson","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0068","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0069","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jnen\/nlz126","article-title":"Limbic predominant age-related TDP-43 encephalopathy (LATE): clinical and neuropathological associations","volume":"79","author":"Besser","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0070","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/aww224","article-title":"TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia","volume":"139","author":"James","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0071","doi-asserted-by":"crossref","first-page":"e1951","DOI":"10.1212\/WNL.0000000000010454","article-title":"Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging","volume":"95","author":"Kapasi","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0072","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-013-1110-0","article-title":"TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies","volume":"126","author":"Arnold","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0073","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bpa.12296","article-title":"Higher prevalence of TDP-43 proteinopathy in cognitively normal Asians: a clinicopathological study on a multiethnic sample","volume":"26","author":"Nascimento","year":"2016","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0074","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/jnen\/nlab098","article-title":"Differences in symptomatic presentation and cognitive performance among participants with LATE-NC compared to FTLD-TDP","volume":"80","author":"Teylan","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0076","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0077","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S1041610214002580","article-title":"Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma?","volume":"27","author":"Landqvist Waldo","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2023.08.017_bib0078","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-140312","article-title":"Psychosis in frontotemporal dementia","volume":"42","author":"Shinagawa","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2023.08.017_bib0079","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/brain\/awaa413","article-title":"Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms","volume":"144","author":"Naasan","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ana.25739","article-title":"Frontotemporal dementia: correlations between psychiatric symptoms and pathology","volume":"87","author":"Scarioni","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0081","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr355","article-title":"Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations","volume":"135","author":"Snowden","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0082","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.30194","article-title":"Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia","volume":"4","author":"Benussi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jagp.2023.08.017_bib0083","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/alzrt141","article-title":"Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease","volume":"4","author":"Takada","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jagp.2023.08.017_bib0084","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/acn3.51363","article-title":"Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum","volume":"8","author":"Devenney","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0085","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awn012","article-title":"Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study","volume":"131","author":"Le Ber","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0086","first-page":"147","article-title":"Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI cohort","volume":"65","author":"Sellami","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2023.08.017_bib0087","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/21678421.2015.1074700","article-title":"Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations","volume":"16","author":"Snowden","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.jagp.2023.08.017_bib0088","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.pmbts.2019.05.009","article-title":"FTD spectrum: neuroimaging across the FTD spectrum","volume":"165","author":"Whitwell","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0089","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318214359f","article-title":"Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia","volume":"76","author":"Elamin","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jnnp-2013-307223","article-title":"Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy","volume":"86","author":"Montuschi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0091","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.743688","article-title":"Factors that influence non-motor impairment across the ALS-FTD spectrum: impact of phenotype, sex, age, onset and disease stage","volume":"12","author":"Devenney","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0092","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnins.2019.00175","article-title":"Psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder","volume":"13","author":"Zucchi","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0093","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1212\/WNL.0000000000004179","article-title":"Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis","volume":"89","author":"Longinetti","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0094","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ana.24801","article-title":"Psychiatric disorders prior to amyotrophic lateral sclerosis","volume":"80","author":"Turner","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0095","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1093\/brain\/awaa315","article-title":"Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease","volume":"143","author":"Liu","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2023.08.017_bib0096","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00702-021-02455-4","article-title":"Increased levels of TAR DNA-binding protein 43 in the hippocampus of subjects with bipolar disorder: a postmortem study","volume":"129","author":"Nascimento","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.jagp.2023.08.017_bib0097","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/mp.2016.262","article-title":"Hippocampal subfield volumes in mood disorders","volume":"22","author":"Cao","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0098","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.23969","article-title":"Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis","volume":"74","author":"Byrne","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0099","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/jamaneurol.2017.2699","article-title":"Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis","volume":"74","author":"O'Brien","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0100","doi-asserted-by":"crossref","first-page":"e1498","DOI":"10.1212\/WNL.0000000000006344","article-title":"Psychiatric disorders in C9orf72 kindreds: study of 1,414 family members","volume":"91","author":"Devenney","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0101","doi-asserted-by":"crossref","first-page":"e32164","DOI":"10.1371\/journal.pone.0032164","article-title":"Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia","volume":"7","author":"Galimberti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jagp.2023.08.017_bib0102","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bdi.12180","article-title":"Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder","volume":"16","author":"Galimberti","year":"2014","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jagp.2023.08.017_bib0103","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2014.01.006","article-title":"Further evidence for plasma progranulin as a biomarker in bipolar disorder","volume":"157","author":"Kittel-Schneider","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2023.08.017_bib0104","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12974-020-01963-6","article-title":"The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response","volume":"17","author":"Lee","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jagp.2023.08.017_bib0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/cells10030676","article-title":"Identification of genetic modifiers of TDP-43: inflammatory activation of astrocytes for neuroinflammation","volume":"10","author":"Kim","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jagp.2023.08.017_bib0106","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnmol.2019.00136","article-title":"Astrocyte, a promising target for mood disorder interventions","volume":"12","author":"Zhou","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0107","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1007\/s12035-018-0947-6","article-title":"Towards a TDP-43-based biomarker for ALS and FTLD","volume":"55","author":"Feneberg","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0108","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrneurol.2017.75","article-title":"Imaging and fluid biomarkers in frontotemporal dementia","volume":"13","author":"Meeter","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0109","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3233\/JAD-160285","article-title":"Diagnostic accuracy of MRI and additional [18F]FDG-PET for behavioral variant frontotemporal dementia in patients with late onset behavioral changes","volume":"53","author":"Vijverberg","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2023.08.017_bib0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","article-title":"Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia","volume":"113","author":"Al Shweiki","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jagp.2023.08.017_bib0111","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40520-020-01554-8","article-title":"The role of neurofilament light chain in frontotemporal dementia: a meta-analysis","volume":"33","author":"Karantali","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jagp.2023.08.017_bib0112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00415-019-09567-8","article-title":"Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders","volume":"267","author":"Katisko","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-180839","article-title":"The frontotemporal dementia versus primary psychiatric disorder (FTD versus PPD) checklist: a bedside clinical tool to identify behavioral variant FTD in patients with late-Onset behavioral changes","volume":"67","author":"Ducharme","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2023.08.017_bib0114","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/brainsci11091209","article-title":"Longitudinal changes in cognition, behaviours, and functional abilities in the three main variants of primary progressive Aphasia: a literature review","volume":"11","author":"de la Sablonniere","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0115","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/jnnp-2017-315995","article-title":"Genetic screening in sporadic ALS and FTD","volume":"88","author":"Turner","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0116","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11910-015-0618-1","article-title":"Non-pharmacological management of behavioral symptoms in frontotemporal and other dementias","volume":"16","author":"Barton","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jagp.2023.08.017_bib0117","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1212\/CON.0000000000000302","article-title":"Psychiatric aspects of dementia","volume":"22","author":"Onyike","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jagp.2023.08.017_bib0118","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11940-014-0319-0","article-title":"Treatment of frontotemporal dementia","volume":"16","author":"Tsai","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0119","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40263-021-00813-0","article-title":"Pharmacotherapy for frontotemporal dementia","volume":"35","author":"Khoury","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jagp.2023.08.017_bib0120","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s40265-022-01769-1","article-title":"Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents","volume":"82","author":"Johnson","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jagp.2023.08.017_bib0121","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jalz.2019.06.4956","article-title":"New directions in clinical trials for frontotemporal lobar degeneration: methods and outcome measures","volume":"16","author":"Boxer","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2023.08.017_bib0122","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/bph.15148","article-title":"Targeting TDP-43 proteinopathy with drugs and drug-like small molecules","volume":"178","author":"Buratti","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0123","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.790114","article-title":"Antibody-based therapeutic interventions for amyotrophic lateral sclerosis: a systematic literature review","volume":"15","author":"Poulin-Briere","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0124","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140420","article-title":"Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons","volume":"5","author":"Pozzi","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jagp.2023.08.017_bib0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.tips.2021.11.015","article-title":"Progranulin as a therapeutic target in neurodegenerative diseases","volume":"43","author":"Rhinn","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0126","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.neurobiolaging.2013.04.022","article-title":"The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding","volume":"34","author":"De Muynck","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jagp.2023.08.017_bib0127","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-1326-7-33","article-title":"Progranulin regulates neuronal outgrowth independent of sortilin","volume":"7","author":"Gass","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jagp.2023.08.017_bib0128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1083\/jcb.200712039","article-title":"Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival","volume":"181","author":"Van Damme","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0129","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1083\/jcb.201502029","article-title":"Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin","volume":"210","author":"Zhou","year":"2015","journal-title":"J Cell Biol"},{"issue":"15 suppl","key":"10.1016\/j.jagp.2023.08.017_bib0130","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1212\/WNL.96.15_supplement.4422","article-title":"AL001 blocks the Sortilin\/PGRN interaction and is a potential therapy for FTD-GRN (4422)","volume":"96","author":"Paul","year":"2021","journal-title":"Neurology"},{"issue":"18 suppl","key":"10.1016\/j.jagp.2023.08.017_bib0131","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1212\/WNL.98.18_supplement.3173","article-title":"A phase 2 study of AL001 in frontotemporal dementia patients carrying a granulin mutation (P5-3.005)","volume":"98","author":"Huang","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2023.08.017_bib0132","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.jagp.2023.08.017_bib0133","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acn3.51165","article-title":"Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations","volume":"7","author":"Hinderer","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0134","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymthe.2018.11.013","article-title":"AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated toxicity","volume":"27","author":"Amado","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jagp.2023.08.017_bib0135","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1002\/alz.040602","article-title":"A brain penetrant progranulin biotherapeutic rescues lysosomal and inflammatory phenotypes in the brain of GRN knockout mice","volume":"16","author":"Logan","year":"2020","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jagp.2023.08.017_bib0136","doi-asserted-by":"crossref","first-page":"16101","DOI":"10.1074\/jbc.M110.193433","article-title":"Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia","volume":"286","author":"Cenik","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jagp.2023.08.017_bib0137","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25584","article-title":"Effect of the histone deacetylase inhibitor FRM-0334 on progranulin levels in patients with progranulin gene haploinsufficiency: a randomized clinical trial","volume":"4","author":"Ljubenkov","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jagp.2023.08.017_bib0138","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/WCO.0000000000000984","article-title":"Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia","volume":"34","author":"Hautbergue","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jagp.2023.08.017_bib0139","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","article-title":"Gene therapy for ALS: a review","volume":"29","author":"Amado","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.jagp.2023.08.017_bib0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of toxicity from ALS\/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jagp.2023.08.017_bib0141","doi-asserted-by":"crossref","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","volume":"110","author":"Lagier-Tourenne","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jagp.2023.08.017_bib0142","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-018-0288-y","article-title":"Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice","volume":"13","author":"Beel","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jagp.2023.08.017_bib0143","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2016-09-736892","article-title":"Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma","volume":"129","author":"Gayle","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jagp.2023.08.017_bib0144","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","article-title":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County dementia Progression Study","volume":"172","author":"Peters","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jagp.2017.10.011","article-title":"Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study","volume":"26","author":"Connors","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2023.08.017_bib0146","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jalz.2012.01.003","article-title":"Predictors of progression to severe Alzheimer's disease in an incidence sample","volume":"9","author":"Rabins","year":"2013","journal-title":"Alzheimers Dement"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748123004001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748123004001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:35:15Z","timestamp":1761021315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748123004001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1064748123004001"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2023.08.017","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2023.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.","name":"copyright","label":"Copyright"}]}}